Pharma-Bio Serv (OTCMKTS:PBSV) Posts Earnings Results, Beats Expectations By $0.35 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) issued its quarterly earnings data on Monday. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.35, reports. The company had revenue of $2.47 million for the quarter, compared to the consensus estimate of $2.70 million. Pharma-Bio Serv had a negative return on equity of 5.61% and a negative net margin of 8.18%.

Pharma-Bio Serv Price Performance

OTCMKTS:PBSV opened at $0.55 on Tuesday. The stock has a market capitalization of $12.61 million, a price-to-earnings ratio of -18.33 and a beta of 0.53. Pharma-Bio Serv has a 52 week low of $0.31 and a 52 week high of $0.90. The firm has a 50 day moving average of $0.55 and a 200 day moving average of $0.57.

Pharma-Bio Serv Announces Dividend

The company also recently disclosed a dividend, which will be paid on Thursday, March 20th. Stockholders of record on Friday, February 28th will be given a $0.075 dividend. The ex-dividend date of this dividend is Friday, February 28th. Pharma-Bio Serv’s payout ratio is currently -250.00%.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.